| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-10 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |